← Back to Search

West Philadelphia Residents for Lung Cancer (LCS Trial)

N/A

Recruiting

Led By Farouk Dako, MD, MPH

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Between 18-89 years' old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

LCS Trial Summary

This trial is trying to develop a program to encourage people to attend lung cancer screenings.

Who is the study for?

This trial is for West Philadelphia residents aged 18-89 who have an upcoming or missed follow-up low dose CT scan (LDCT) for lung cancer screening. It's not open to those living outside this area, without a scheduled LDCT, or outside the specified age range.Check my eligibility

What is being tested?

The study is testing a community support program designed to increase attendance at lung cancer screenings by providing transportation assistance.See study design

What are the potential side effects?

Since this trial involves a support program with transportation and does not include medication or medical procedures, there are no direct side effects associated with the interventions being studied.

LCS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 89 years old.

LCS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Develop a community support program for lung cancer screening adherence

Secondary outcome measures

Measure the impact of the community support program in improving adherence to lung cancer screening follow-up

LCS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: West Philadelphia ResidentsExperimental Treatment1 Intervention

For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions

Group II: Non West Philadelphia ResidentsActive Control1 Intervention

For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,881,687 Total Patients Enrolled

Farouk Dako, MD, MPHPrincipal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently accepting new participants?

"Indeed, as per the information available on clinicaltrials.gov, this trial is currently in active recruitment mode. The initial posting of the trial occurred on February 10th, 2023 and it was last edited or updated on January 4th, 2024."

Answered by AI

Is the trial open to participants who have reached the age of 20 and above?

"To be eligible for this study, individuals must fall within the age range of 18 to 89 years. It is worth noting that there are currently 44 trials available specifically for participants under the age of 18, and an additional 1586 trials targeting those over the age of 65."

Answered by AI

What is the overall count of participants involved in this clinical investigation?

"Indeed, the information available on clinicaltrials.gov confirms that this particular clinical trial is actively seeking eligible participants. The study was originally posted on February 10th, 2023 and was last updated on January 4th, 2024. The research team aims to recruit a total of 600 patients from a single designated location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Community Support Program for Lung Cancer Screening

2023. "Community Support Program for Lung Cancer Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06207435.